Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.8%

22 terminated/withdrawn out of 378 trials

Success Rate

90.4%

+3.9% vs industry average

Late-Stage Pipeline

14%

53 trials in Phase 3/4

Results Transparency

6%

13 of 206 completed trials have results

Key Signals

38 recruiting13 with results16 terminated6 withdrawn

Enrollment Performance

Analytics

N/A
133(53.0%)
Phase 2
50(19.9%)
Phase 3
31(12.4%)
Phase 4
22(8.8%)
Phase 1
14(5.6%)
Early Phase 1
1(0.4%)
251Total
N/A(133)
Phase 2(50)
Phase 3(31)
Phase 4(22)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (378)

Showing 20 of 378 trials
NCT07514520Active Not Recruiting

Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION

Role: lead

NCT04639635Suspended

CNGB1 and Allied Disorders

Role: collaborator

NCT07504965Recruiting

Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly

Role: lead

NCT06593080Not ApplicableRecruiting

The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis

Role: collaborator

NCT05179993Active Not Recruiting

Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment

Role: collaborator

NCT04845503Not ApplicableActive Not Recruiting

Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer

Role: collaborator

NCT05237453Not ApplicableActive Not Recruiting

Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer

Role: collaborator

NCT07455097Active Not Recruiting

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)

Role: collaborator

NCT04225390Phase 2Completed

Preconditioning of Tumor, Tumor Microenvironment and the Immune System to Immunotherapy

Role: collaborator

NCT05656469Not ApplicableRecruiting

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

Role: collaborator

NCT07336199Recruiting

Pairing Subjective Patient Rating and DBS Programming

Role: lead

NCT07326124Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study -ASSIST

Role: collaborator

NCT07008560Active Not Recruiting

Spatiotemporal Associations Between the COVID-19 Pandemic and Cancer Diagnoses in Bavaria

Role: collaborator

NCT06778564Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Role: collaborator

NCT05114213Phase 2Terminated

MR-Guided Adaptive SBRT of Primary Tumor for Pain Control in Metastatic PDAC

Role: lead

NCT07061600Not ApplicableCompleted

Enhancing Depression Literacy and Reducing Stigma in Adolescents Through Social Media

Role: lead

NCT07100548Completed

A Qualitative Analysis of Youth Responses to Depression Education Delivered on Social Media

Role: lead

NCT05099471Phase 2Recruiting

Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia

Role: collaborator

NCT07131956Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Role: collaborator

NCT06323031Recruiting

Spontaneous Eye Blinking in Disorders of Consciousness

Role: collaborator